Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$2.33 - $5.07 $372 - $811
160 Added 45.07%
515 $1,000
Q2 2023

Jul 28, 2023

SELL
$4.67 - $6.55 $499 - $700
-107 Reduced 23.16%
355 $1,000
Q1 2023

Apr 26, 2023

BUY
$4.95 - $6.09 $529 - $651
107 Added 30.14%
462 $2,000
Q4 2022

Jan 24, 2023

SELL
$5.09 - $9.05 $468 - $832
-92 Reduced 20.58%
355 $0
Q3 2022

Nov 10, 2022

BUY
$3.5 - $7.2 $1,564 - $3,218
447 New
447 $3,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $104M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.